BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24439759)

  • 1. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
    Greenstein VC; Lima de Carvalho JR; Parmann R; Amaro-Quireza L; Lee W; Hood DC; Tsang SH; Sparrow JR
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):41. PubMed ID: 32976563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
    Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy.
    Almony A; Garg S; Peters RK; Mamet R; Tsong J; Shibuya B; Kitridou R; Sadun AA
    Br J Ophthalmol; 2005 May; 89(5):569-74. PubMed ID: 15834087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.
    Jeltsch BM; Sarraf D; Madjdpour D; Hanson JVM; Pfiffner FK; Koller S; Berger W; Barthelmes D; Al-Sheikh M
    Retin Cases Brief Rep; 2024 May; 18(3):351-354. PubMed ID: 36857194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERG findings in patients using hydroxychloroquine.
    Tzekov RT; Serrato A; Marmor MF
    Doc Ophthalmol; 2004 Jan; 108(1):87-97. PubMed ID: 15104171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing the bull's eye.
    Gilbert ME; Savino PJ
    Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.
    Lai TY; Ngai JW; Chan WM; Lam DS
    Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of photoreceptor outer segment in acute zonal occult outer retinopathy.
    Li D; Kishi S
    Arch Ophthalmol; 2007 Sep; 125(9):1194-200. PubMed ID: 17846358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hydroxychloroquine toxicity.
    Bienfang DC
    Arch Ophthalmol; 2007 Nov; 125(11):1585; author reply 1585. PubMed ID: 17998532
    [No Abstract]   [Full Text] [Related]  

  • 17. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
    Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal toxicity secondary to Plaquenil therapy.
    Hanna B; Holdeman NR; Tang RA; Schiffman JS
    Optometry; 2008 Feb; 79(2):90-4. PubMed ID: 18215798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early paracentral visual field loss in patients taking hydroxychloroquine.
    Elder M; Rahman AM; McLay J
    Arch Ophthalmol; 2006 Dec; 124(12):1729-33. PubMed ID: 17159032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal visual evoked potential, multifocal electroretinography, and optical coherence tomography in the diagnosis of subclinical loss of vision.
    Hedges TR; Quireza ML
    Ophthalmol Clin North Am; 2004 Mar; 17(1):89-105. PubMed ID: 15102515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.